Recovery of Infectious Human Parainfluenza Virus Type 3 from cDNA

This publication has 31 references indexed in Scilit:

• Minimum Protein Requirements for Transcription and RNA Replication of a Minigenome of Human Parainfluenza Virus Type 3 and Evaluation of the Rule of Six
  Virology, 1997
• Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants
  The Pediatric Infectious Disease Journal, 1996
• Genetic manipulation of non-segmented negative-strand RNA viruses
  Journal of General Virology, 1996
• Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.
  Proceedings of the National Academy of Sciences, 1995
• A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children
  The Journal of Infectious Diseases, 1995
• A Live Attenuated Bovine Parainfluenza Virus Type 3 Vaccine Is Safe, Infectious, Immunogenic, and Phenotypically Stable in Infants and Children
  The Journal of Infectious Diseases, 1995
• Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys
  Virus Research, 1992
• Paramyxoviridae: Transcription and Replication
  Published by Elsevier ,1991
• Molecular cloning and sequence analysis of the human parainfluenza 3 virus gene encoding the L protein
  Virology, 1988
• Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers
  Journal of Medical Virology, 1982